Background
Human immunity triggered by natural malaria infections impedes parasite transmission from humans to mosquitoes, leading to interest in transmission-blocking vaccines. However, immunity characteristics, especially strain specificity, remain largely unexplored. We investigated naturally acquired transmission-blocking immunity (TBI) against Plasmodium vivax, a major malaria parasite.
Methods
Using the direct membrane-feeding assay (DMFA), we assessed TBI in plasma samples and examined the role of antibodies by removing immunoglobulins (Ig) through Protein G/L adsorption before mosquito feeding. Strain specificity was evaluated by conducting DMFA with plasma exchange.
Results
Blood samples from 47 P. vivax patients were evaluated, with 37 samples successfully infecting mosquitoes. Among these, 26 plasmas showed inhibition before Ig-depletion. Despite substantial Ig removal, four plasmas still exhibited notable inhibition, while 22 plasmas had reduced blocking activity. Testing against heterologous strains revealed some plasma samples with broad TBI and others with strain-specific TBI.
Conclusions
Our findings indicate that naturally acquired TBI is mainly mediated by antibodies, with possible contributions from other serum factors. The transmission-blocking activity of plasma samples varied depending on the tested parasite strain, suggesting single polymorphic or multiple targets for naturally acquired TBI. These observations improve understanding of immunity against P. vivax and hold implications for transmission-blocking vaccine development.